Sarah Cannon Research Institute Oncology Partners is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute Oncology Partners has participated in 16 clinical trials with 14 currently active.
Therapeutic areas: Solid Malignancies, Hematologic Malignancies, Metastatic Hepatocellular Carcinoma.
Sponsors: Immunome, Inc., Tyra Biosciences, Inc, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute Oncology Partners has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute Oncology Partners has 16 clinical trials on record, with 14 currently active. Their work covers Solid Malignancies, Hematologic Malignancies, Metastatic Hepatocellular Carcinoma.
Sarah Cannon Research Institute Oncology Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.